Results 181 to 190 of about 34,947 (279)

Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney disease

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3568-3581, May 2026.
Abstract The mineralocorticoid receptor (MR) has a multifaceted role in normal physiologic functions. However, research has uncovered the deleterious consequences of overactivation of the MR. It has been implicated in chronic kidney disease (CKD) via its strong association with glomerulosclerosis, interstitial fibrosis, proteinuria, and decline in ...
Amy K. Mottl, Kamlesh Khunti, Chantal Mathieu   +2 more
wiley   +1 more source

The diagnosis and subclassification of heart failure with preserved ejection fraction: a review. [PDF]

Heart Fail Rev
Creegan D, Starling RC, Hameed A, Daly MJ, O'Neill J.   +4 more
europepmc   +1 more source

Impact of specialised endocrinology care on metabolic control and healthcare utilisation outcomes after kidney transplantation in patients with diabetes: A 12‐month observational cohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4082-4090, May 2026.
Abstract Aims To evaluate whether an endocrinology‐integrated transplant clinic and differing healthcare delivery models are associated with metabolic outcomes during the first year after kidney transplantation in recipients with pre‐existing diabetes.
Joaquin Lado‐Abeal, Francisco Gude, Maria Jose Ginzo‐Villamayor, Khalid Al‐Zubaidi, Jacqueline C. Stocking, Gemma Rodriguez‐Carnero, Aili Guo, Prasanth Surampudi, Caroline Lenaerts, Vedesh K. Babu, Deborah Plante, Yihung Huang, Antia Fernandez‐Pombo   +12 more
wiley   +1 more source

Healthcare Resource Utilisation and Cost of Obesity and Related Complications in the United States: A Systematic Literature Review

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4121-4136, May 2026.
ABSTRACT Aim Obesity is an increasingly prevalent, chronic, heterogeneous disease, associated with a variety of obesity‐related complications (ORCs). This systematic literature review assessed US healthcare resource utilisation (HCRU) and costs (direct and indirect) for people living with obesity (PwO) or overweight and ORCs.
Jaime P. Almandoz, Jamy D. Ard, Chellse Gazda, Shenelle Edwards‐Hampton   +3 more
wiley   +1 more source

Early administration of renin-angiotensin system inhibitors improves survival and cardiac remodeling in heart failure with preserved ejection fraction. [PDF]

PLoS One
Kono Y, Sonoda K, Ohtake K, Ota A, Yamamoto S, Nakayama H, Fukuoka T, Kawai Y, Tago H, Watanabe N, Sato I, Hirohata S, Kitamori K, Watanabe S.   +13 more
europepmc   +1 more source

Peripartum HFpEF

JACC: Advances
Salva Yurista, Priya Wadhera, Robert A. Eder, Uri Elkayam, Omar K. Siddiqi   +4 more
openaire   +1 more source

Understanding HFpEF With Obesity

JACC: Basic to Translational Science, 2021
openaire   +1 more source

T Cell Receptor Repertoires Across the Continuum of Vascular, Myocardial, and Age‐Related Diseases

Immunological Reviews, Volume 339, Issue 1, May 2026.
ABSTRACT Cardiovascular diseases (CVD) are shaped by a complex interplay with immune mechanisms. In particular, the distinct roles of antigen‐specific T cell mechanisms are emerging as critical determinants across a broad spectrum of conditions, ranging from atherosclerosis, myocardial infarction (MI), heart failure (HF), and myocarditis. Because these
Leon Richter, João Dias‐Ferreira, Gustavo Campos Ramos, DiyaaElDin Ashour   +3 more
wiley   +1 more source

A prediction model for the risk of developing HFpEF during hospitalization in patients with acute myocardial infarction. [PDF]

Int J Cardiol Heart Vasc
Liu Z, Fan Y, Su Y, Wu S, Feng S, Pan Y, Li H, Jiang C, Wang J, Guo J, Chen D, Bian N.   +11 more
europepmc   +1 more source

Clinical Advances in Heart Failure with Preserved Ejection Fraction: A Systematic Review of Therapeutic and Mechanistic Evidence. [PDF]

Vasc Health Risk Manag
Parizad R, Hatwal J, Taban Sadeghi M, Brar A, Desai R, Batta A, Mohan B.   +6 more
europepmc   +1 more source